BioSpace News Archive

Policy

Government of Canada introduces new measures to address COVID-19 Omicron variant of concern

Public health authorities in South Africa have confirmed that a new COVID-19 variant of concern has been detected in that country.

November 26, 2021
·
5 min read
Drug Development

Starpharma releases positive DEP® phase 2 interim results in prostate cancer

Melbourne biotech company Starpharma announced positive interim results from the prostate cancer cohort in its ongoing phase 2 trial of DEP® cabazitaxel.

November 26, 2021
·
4 min read
Drug Development

Ocugen, Inc. Provides an Update on its Investigational New Drug Application with U.S. FDA to Initiate a Phase 3 Clinical Trial Evaluating COVID-19 Vaccine Candidate COVAXIN™ (BBV152)

Ocugen, Inc. announced that the U.S. Food and Drug Administration has issued a clinical hold on the Company’s Investigational New Drug application to evaluate the COVID-19 vaccine candidate, BBV152, known as COVAXIN™ outside the United States.

November 26, 2021
·
7 min read
Pharm Country

Enzychem to Partner with Zydus Cadila to Manufacture COVID-19 Plasmid DNA Vaccine in Korea

Enzychem Lifesciences and Cadila Healthcare Ltd, a part of the Zydus Group, announced that they have entered a Manufacturing License and Technology Transfer Agreement for the world’s first plasmid DNA vaccine.

November 26, 2021
·
3 min read
Policy

Statement from the Chief Public Health Officer of Canada on November 26, 2021

The COVID-19 pandemic continues to create stress and anxiety for many Canadians, particularly those who do not have ready access to their regular support networks.

November 26, 2021
·
7 min read
Orexo provides information about its new proprietary drug delivery platform - amorphOXTM

Orexo AB, provides information about its new proprietary drug delivery platform, amorphOXTM, a novel and inventive powder-based technology with significant potential.

November 26, 2021
·
4 min read
Business

Immunovia appoints new Senior Director Investor Relations and Corporate Communications

Immunovia AB announces that Tobias Bülow has been appointed new Senior Director Investor Relations and Corporate Communications, taking up his position January 15.

November 26, 2021
·
2 min read
Vitrolife publishes prospectus in connection with the admission to trading on Nasdaq Stockholm due to non-cash issue

Vitrolife AB publishes a prospectus for the admission to trading of newly issued shares in Vitrolife on Nasdaq Stockholm’s main market in connection with a non-cash issue through which Vitrolife acquires all shares in Mendel Holdco S.L. and thereby indirectly all shares in Igenomix S.L.

November 26, 2021
·
2 min read
Kingston Health Sciences Centre Expands Lung Diagnostic Assessment Program to Napanee, ON

Merck Canada is proud to announce that the Kingston Health Sciences Centre, first place winner of the Lung Cancer Innovation Challenge, has launched a Lung Diagnostic Assessment Program at the Lennox & Addington County General Hospital in Napanee, Ontario.

November 26, 2021
·
5 min read
BioCapital

QIAGEN reaffirms effectiveness of its SARS-CoV-2 PCR tests in light of the new coronavirus variant B.1.1.529

QIAGEN N.V. announced its polymerase chain reaction tests remain accurate and effective in detecting SARS-CoV-2 infections in light of the emergence of a new variant of concern detected in South Africa.

November 26, 2021
·
6 min read